H. Minami

Acidic Region Residues 1680–1684 in the A3 Domain of Factor VIII Contain a Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg1689

K. Nogami, Yuto Nakajima, H. Minami, 2021, Thrombosis and Haemostasis.

The factor VIII heavy chain improves emicizumab-tenase assembly to enhance the factor VIII-mimicking cofactor activity.

K. Nogami, M. Shima, K. Hattori, 2018, Thrombosis research.

Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry

K. Nogami, M. Shima, K. Ogiwara, 2015, Journal of thrombosis and haemostasis : JTH.

Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro

K. Nogami, M. Shima, T. Kitazawa, 2018, Journal of thrombosis and haemostasis : JTH.

Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow‐chamber system

K. Nogami, M. Shima, K. Hosokawa, 2016, Journal of thrombosis and haemostasis : JTH.

Use of a microchip flow-chamber system as a screening test for platelet storage pool disease

K. Nogami, M. Shima, K. Hosokawa, 2015, International Journal of Hematology.

The first case of int1h‐related inversion in Japanese haemophilia A patients

K. Nogami, M. Shima, H. Minami, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.